Ensysce Biosciences (ENSC) Short Interest Ratio & Short Volume $2.13 -0.03 (-1.39%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$2.12 -0.01 (-0.47%) As of 07/18/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Ensysce Biosciences Short Interest DataEnsysce Biosciences (ENSC) has a short interest of 272,800 shares, representing 12.49% of the float (the number of shares available for trading by the public). This marks a -6.96% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 951,334 shares to cover all short positions.Current Short Interest272,800 sharesPrevious Short Interest293,200 sharesChange Vs. Previous Month-6.96%Dollar Volume Sold Short$608.34 thousandShort Interest Ratio0.2 Days to CoverLast Record DateJune 30, 2025Outstanding Shares2,370,000 sharesShort Percent of Float12.49%Today's Trading Volume76,623 sharesAverage Trading Volume951,334 sharesToday's Volume Vs. Average8% Short Selling Ensysce Biosciences? Sign up to receive the latest short interest report for Ensysce Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENSC Short Interest Over TimeENSC Days to Cover Over TimeENSC Percentage of Float Shorted Over Time Ensysce Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025272,800 shares $608.34 thousand -7.0%12.5%0.2 $2.23 6/15/2025293,200 shares $606.92 thousand +199.2%13.4%0.2 $2.07 5/31/202598,000 shares $214.62 thousand -71.5%8.1%0.1 $2.19 5/15/2025344,400 shares $737.02 thousand +138.3%28.6%0.2 $2.14 4/30/2025144,500 shares $436.39 thousand +7.1%N/A0.1 $3.02 4/15/2025134,900 shares $302.18 thousand +328.3%11.2%0.1 $2.24 3/31/202531,500 shares $80.64 thousand +43.2%2.6%0.8 $2.56 3/15/202522,000 shares $85.58 thousand -43.3%1.8%0.4 $3.89 2/28/202538,800 shares $209.13 thousand -1.0%3.2%0.5 $5.39 2/15/202539,200 shares $227.36 thousand +3.7%3.3%0.4 $5.80 Get the Latest News and Ratings for ENSC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ensysce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/202537,800 shares $259.69 thousand -31.2%N/A0.1 $6.87 1/15/202554,900 shares $393.08 thousand -35.2%N/A0 $7.16 12/31/202484,700 shares $689.46 thousand +85.8%N/A0 $8.14 12/15/202445,600 shares $256.27 thousand -60.5%N/A0 $5.62 11/30/2024115,300 shares $854.37 thousand -97.6%N/A0.1 $7.41 11/15/20244,850,000 shares $3.25 million -23.6%N/A0.2 $0.67 10/31/20246,350,000 shares $3.66 million +5,514.5%43.4%0.2 $0.58 10/15/2024113,100 shares $19.05 thousand -37.2%0.8%0 $0.17 9/30/2024180,200 shares $43.25 thousand -11.4%1.6%0.1 $0.24 9/15/2024203,300 shares $66.28 thousand -70.5%1.9%0.1 $0.33 8/31/2024689,400 shares $272.31 thousand +3,885.0%6.3%0.4 $0.40 8/15/202417,300 shares $6.80 thousand -92.7%0.2%0.2 $0.39 7/31/2024235,500 shares $105.98 thousand +2.5%3.2%1.7 $0.45 7/15/2024229,800 shares $106.05 thousand -16.6%3.2%1.7 $0.46 6/30/2024275,500 shares $139.54 thousand +4.0%3.8%2 $0.51 6/15/2024264,800 shares $137.70 thousand +37.1%3.6%1.8 $0.52 5/31/2024193,200 shares $111.09 thousand +40.0%2.7%1.4 $0.58 5/15/2024138,000 shares $85.44 thousand +1,337.5%1.9%0.9 $0.62 4/30/20249,600 shares $5.68 thousand +134.2%0.1%0 $0.59 4/15/20244,100 shares $2.79 thousand -76.6%0.1%0 $0.68 3/31/202417,500 shares $13.83 thousand -69.0%0.6%0 $0.79 3/15/202456,500 shares $44.84 thousand -34.4%1.9%0 $0.79 2/29/202486,100 shares $80.28 thousand +40.9%3.0%0.1 $0.93 2/15/202461,100 shares $54.38 thousand -91.0%2.1%0 $0.89 1/31/2024678,500 shares $1.10 million +175.5%23.3%0.5 $1.62 1/15/2024246,300 shares $337.43 thousand +9.1%8.8%0.2 $1.37 12/31/2023225,700 shares $239.24 thousand +35.2%8.0%1 $1.06 12/15/2023167,000 shares $185.37 thousand +25.3%5.9%0.8 $1.11 11/30/2023133,300 shares $151.96 thousand +96.6%4.8%0.9 $1.14 11/15/202367,800 shares $59.81 thousand +11.3%2.4%0.9 $0.88The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a 10/31/202360,900 shares $56.09 thousand +161.4%2.2%0.8 $0.92 10/15/202323,300 shares $33.55 thousand +9.9%0.9%0.3 $1.44 9/30/202321,200 shares $29.26 thousand -20.0%0.8%0.4 $1.38 9/15/202326,500 shares $46.38 thousand -4.0%1.1%0.1 $1.75 8/31/202327,600 shares $51.06 thousand -2.1%1.1%0.1 $1.85 8/15/202328,200 shares $54.99 thousand -36.8%1.0%0.1 $1.95 7/31/202344,600 shares $89.65 thousand +81.3%1.9%0.1 $2.01 7/15/202324,600 shares $48.22 thousand +24.9%1.4%0 $1.96 6/30/202319,700 shares $36.05 thousand -2.5%2.4%0 $1.83 6/15/202320,200 shares $47.47 thousand +6.3%2.5%0 $2.35 5/31/202319,000 shares $45.03 thousand -83.3%2.3%0 $2.37 5/15/2023113,600 shares $349.89 thousand +43.8%11.0%0.2 $3.08 4/30/202379,000 shares $296.25 thousand +62.2%6.3%0.1 $3.75 4/15/202348,700 shares $194.37 thousand +5.9%3.9%0.2 $3.99 3/31/202346,000 shares $2.68 million -92.1%6.9%0.2 $58.32 3/15/2023580,700 shares $351.90 thousand +194.3%17.3%0.3 $0.61 2/28/2023197,300 shares $96.48 thousand -28.3%5.7%0.1 $0.49 2/15/2023275,200 shares $167.87 thousand -47.6%7.2%0.1 $0.61 1/31/2023525,000 shares $367.50 thousand +631.2%9.9%0.2 $0.70 1/15/202371,800 shares $55.32 thousand -9.9%1.6%0 $0.77 12/30/202279,700 shares $59.78 thousand -44.4%1.7%0.1 $0.75 12/15/2022143,400 shares $131.34 thousand -54.6%7.1%0.1 $0.92 11/30/2022315,700 shares $915.53 thousand +128.9%17.3%0.3 $2.90 11/15/2022137,900 shares $297.86 thousand -8.1%7.5%0.2 $2.16 10/31/2022150,000 shares $484.50 thousand -78.5%10.1%0.8 $3.23 10/15/2022698,700 shares $144.63 thousand -39.8%3.2%0.5 $0.21 9/30/20221,160,000 shares $249.40 thousand -27.5%5.3%1.1 $0.22 9/15/20221,600,000 shares $551.84 thousand +134.6%7.4%1 $0.34 8/31/2022681,900 shares $288.03 thousand -5.0%3.3%0.5 $0.42 8/15/2022717,500 shares $350.21 thousand +30.6%3.5%0.6 $0.49 7/31/2022549,200 shares $282.78 thousand -12.1%2.9%0.5 $0.51 7/15/2022624,900 shares $365.63 thousand +20.0%3.3%0.5 $0.59 6/30/2022520,600 shares $452.09 thousand +45.0%2.9%0.4 $0.87 6/15/2022359,100 shares $169.14 thousand +52.9%2.0%0.4 $0.47 5/31/2022234,800 shares $131.65 thousand +94.7%1.5%0.2 $0.56 5/15/2022120,600 shares $81.01 thousand -83.4%0.9%0.1 $0.67 4/30/2022724,300 shares $796.73 thousand +65.0%7.6%0.9 $1.10 4/15/2022439,000 shares $469.73 thousand +41.5%4.6%0.6 $1.07 3/31/2022310,200 shares $353.63 thousand +139.7%4.0%0.3 $1.14 3/15/2022129,400 shares $139.75 thousand -64.0%1.7%0.1 $1.08 2/28/2022359,300 shares $402.42 thousand +154.5%4.7%0.1 $1.12 2/15/2022141,200 shares $211.80 thousand -59.6%1.8%0 $1.50 1/31/2022349,700 shares $608.48 thousand +229.9%4.5%0 $1.74 1/15/2022106,000 shares $347.68 thousand -86.8%N/A0 $3.28 12/31/2021801,600 shares $3.77 million -7.7%10.4%0.1 $4.70 12/15/2021868,100 shares $3.57 million +702.3%11.2%0.1 $4.11 11/30/2021108,200 shares $170.96 thousand +18.1%1.4%0 $1.58 11/15/202191,600 shares $196.02 thousand -58.3%1.2%0.1 $2.14 10/29/2021219,900 shares $483.78 thousand +140.3%2.8%0.2 $2.20 10/15/202191,500 shares $216.86 thousand -38.8%1.2%0 $2.37The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a 9/30/2021149,400 shares $452.68 thousand +280.2%1.6%0.1 $3.03 9/15/202139,300 shares $120.65 thousand -20.1%0.4%0 $3.07 8/31/202149,200 shares $155.47 thousand +59.7%0.5%0 $3.16 8/13/202130,800 shares $101.02 thousand No Change0.3%0 $3.28 ENSC Short Interest - Frequently Asked Questions What is Ensysce Biosciences' current short interest? Short interest is the volume of Ensysce Biosciences shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 272,800 shares of ENSC short. 12.49% of Ensysce Biosciences' shares are currently sold short. Learn More on Ensysce Biosciences' current short interest. What is a good short interest percentage for Ensysce Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.49% of Ensysce Biosciences' floating shares are currently sold short. Is Ensysce Biosciences' short interest increasing or decreasing? Ensysce Biosciences saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 272,800 shares, a decline of 7.0% from the previous total of 293,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ensysce Biosciences' short interest compare to its competitors? 12.49% of Ensysce Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Ensysce Biosciences: Relmada Therapeutics, Inc. (2.26%), Reviva Pharmaceuticals Holdings, Inc. (10.24%), Finch Therapeutics Group, Inc. (0.01%), VYNE Therapeutics Inc. (3.46%), Cingulate Inc. (4.75%), BioLineRx Ltd. (4.46%), MEI Pharma, Inc. (0.08%), Aytu BioPharma Inc. (9.12%), Hoth Therapeutics, Inc. (4.53%), Carisma Therapeutics Inc. (4.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Ensysce Biosciences stock? Short selling ENSC is an investing strategy that aims to generate trading profit from Ensysce Biosciences as its price is falling. ENSC shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ensysce Biosciences? A short squeeze for Ensysce Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENSC, which in turn drives the price of the stock up even further. How often is Ensysce Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENSC, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Relmada Therapeutics Short Interest Reviva Pharmaceuticals Short Interest Finch Therapeutics Group Short Interest VYNE Therapeutics Short Interest Cingulate Short Interest BioLineRx Short Interest MEI Pharma Short Interest Aytu BioPharma Short Interest Hoth Therapeutics Short Interest Carisma Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENSC) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ensysce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENSC Stock Alerts